Alkermes plc Stock
Alkermes plc Stock
Alkermes plc gained 0.680% compared to yesterday.
Alkermes plc is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 37 € shows a positive potential of 24.16% compared to the current price of 29.8 € for Alkermes plc.
Pros and Cons of Alkermes plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Alkermes plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 0.680% | -0.667% | 26.271% | 13.740% | 26.271% | 12.879% | 87.421% |
| Icon plc | 0.860% | -5.526% | -0.958% | -28.715% | -41.297% | -52.151% | - |
| United Therapeutics | -1.530% | -0.429% | 5.568% | 95.860% | 14.042% | 128.137% | 184.971% |
| Ligand Pharmaceuticals | -0.570% | -2.235% | -2.778% | 92.308% | 5.422% | 161.194% | 34.564% |
Comments
Alkermes (ALKS) had its price target lowered by Piper Sandler from $45.00 to $43.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes (ALKS) had its price target lowered by Royal Bank Of Canada from $47.00 to $45.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat
Alkermes (ALKS) had its price target raised by Wells Fargo & Company from $37.00 to $43.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ALKS provided by MarketBeat